D. E. Shaw & Co., Inc. Angiodynamics Inc Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Angiodynamics Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 247,074 shares of ANGO stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

247,074

Previous 218,581 13.04%

Holding current value

$2.3 Million

Previous $1.7 Million 33.12%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.88 - $9.33 $167,538 - $265,839	28,493 Added 13.04%	247,074 $2.26 Million
Q3 2024 Nov 14, 2024	SELL	$5.51 - $7.84 $540,922 - $769,660	-98,171 Reduced 30.99%	218,581 $1.7 Million
Q2 2024 Aug 14, 2024	SELL	$5.65 - $7.03 $1.45 Million - $1.81 Million	-257,408 Reduced 44.83%	316,752 $1.92 Million
Q1 2024 May 15, 2024	SELL	$5.27 - $8.03 $159,633 - $243,236	-30,291 Reduced 5.01%	574,160 $3.37 Million
Q4 2023 Feb 14, 2024	SELL	$6.17 - $8.04 $503,151 - $655,645	-81,548 Reduced 11.89%	604,451 $4.74 Million
Q3 2023 Nov 14, 2023	BUY	$7.02 - $10.32 $2.04 Million - $3.01 Million	291,210 Added 73.76%	685,999 $5.01 Million
Q2 2023 Aug 14, 2023	BUY	$8.29 - $11.16 $1.23 Million - $1.66 Million	148,373 Added 60.21%	394,789 $4.12 Million
Q1 2023 May 15, 2023	BUY	$9.1 - $15.48 $423,231 - $719,959	46,509 Added 23.27%	246,416 $2.55 Million
Q4 2022 Feb 14, 2023	BUY	$12.06 - $21.55 $2.41 Million - $4.31 Million	199,907 New	199,907 $2.75 Million
Q2 2022 Aug 15, 2022	SELL	$17.83 - $24.49 $20,023 - $27,502	-1,123 Reduced 4.59%	23,327 $451,000
Q1 2022 May 16, 2022	SELL	$20.46 - $29.16 $564,757 - $804,903	-27,603 Reduced 53.03%	24,450 $527,000
Q4 2021 Feb 14, 2022	SELL	$24.35 - $30.97 $1.08 Million - $1.37 Million	-44,344 Reduced 46.0%	52,053 $1.44 Million
Q3 2021 Nov 15, 2021	SELL	$23.36 - $29.2 $568,208 - $710,260	-24,324 Reduced 20.15%	96,397 $2.5 Million
Q2 2021 Aug 16, 2021	SELL	$22.39 - $28.07 $1.73 Million - $2.17 Million	-77,227 Reduced 39.01%	120,721 $3.28 Million
Q1 2021 May 17, 2021	SELL	$15.44 - $23.4 $688,068 - $1.04 Million	-44,564 Reduced 18.38%	197,948 $4.63 Million
Q4 2020 Feb 16, 2021	SELL	$10.34 - $15.33 $437,774 - $649,041	-42,338 Reduced 14.86%	242,512 $3.72 Million
Q3 2020 Nov 16, 2020	SELL	$8.26 - $12.74 $423,655 - $653,434	-51,290 Reduced 15.26%	284,850 $3.44 Million
Q2 2020 Aug 14, 2020	SELL	$9.05 - $12.01 $501,252 - $665,197	-55,387 Reduced 14.15%	336,140 $3.42 Million
Q1 2020 May 15, 2020	SELL	$8.33 - $16.9 $467,862 - $949,205	-56,166 Reduced 12.55%	391,527 $4.08 Million
Q4 2019 Feb 14, 2020	BUY	$14.23 - $18.16 $2.82 Million - $3.6 Million	198,349 Added 79.55%	447,693 $7.17 Million
Q3 2019 Nov 14, 2019	BUY	$17.78 - $21.89 $997,724 - $1.23 Million	56,115 Added 29.04%	249,344 $4.59 Million
Q2 2019 Aug 14, 2019	SELL	$18.78 - $25.01 $845,494 - $1.13 Million	-45,021 Reduced 18.9%	193,229 $3.81 Million
Q1 2019 May 15, 2019	SELL	$19.43 - $23.46 $839,142 - $1.01 Million	-43,188 Reduced 15.35%	238,250 $5.45 Million
Q4 2018 Feb 14, 2019	BUY	$18.9 - $22.06 $676,582 - $789,703	35,798 Added 14.57%	281,438 $5.67 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $24.23 $569,504 - $728,184	30,053 Added 13.94%	245,640 $5.34 Million
Q2 2018 Aug 14, 2018	BUY	$17.42 - $23.0 $1.04 Million - $1.37 Million	59,465 Added 38.09%	215,587 $4.79 Million
Q1 2018 May 15, 2018	SELL	$15.71 - $17.7 $293,305 - $330,459	-18,670 Reduced 10.68%	156,122 $2.69 Million
Q4 2017 Feb 14, 2018	BUY	$16.56 - $17.8 $476,778 - $512,479	28,791 Added 19.72%	174,792 $2.91 Million
Q3 2017 Nov 14, 2017	BUY	$16.09 - $18.76 $2.35 Million - $2.74 Million	146,001	146,001 $2.5 Million

Others Institutions Holding ANGO

# of Institutions

143

Shares Held

34.4M

Call Options Held

273K

Put Options Held

23.9K

View Full List

About ANGIODYNAMICS INC

Ticker ANGO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 39,107,800
Market Cap $363M
Description
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...

More about ANGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account